Literature DB >> 2617619

The effects of malaria chemoprophylaxis given by traditional birth attendants on the course and outcome of pregnancy.

B M Greenwood1, A M Greenwood, R W Snow, P Byass, S Bennett, A B Hatib-N'Jie.   

Abstract

A trial of malaria chemoprophylaxis given by traditional birth attendants was undertaken in a rural area of The Gambia where access to antenatal clinics is difficult. Women received one or more doses of Maloprim or placebo from a traditional birth attendant during 1049 of 1208 pregnancies (87%) recorded in 16 villages over a 3-year period. Primigravidae who received Maloprim had a lower parasite rate and a significantly higher mean packed cell volume than primigravidae who received placebo, and their babies were significantly heavier (6% low birth weight vs 22%). In multigravidae chemoprophylaxis reduced malaria parasitaemia but it had no beneficial effect on haemoglobin level and much less effect on birth weight than was observed in primigravidae. However, the mean birth weight of babies born to grandemultigravidae who received chemoprophylaxis was significantly higher than that of babies born to grandemultigravidae who did not.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2617619     DOI: 10.1016/0035-9203(89)90362-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  31 in total

Review 1.  Lay health workers in primary and community health care for maternal and child health and the management of infectious diseases.

Authors:  Simon Lewin; Susan Munabi-Babigumira; Claire Glenton; Karen Daniels; Xavier Bosch-Capblanch; Brian E van Wyk; Jan Odgaard-Jensen; Marit Johansen; Godwin N Aja; Merrick Zwarenstein; Inger B Scheel
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

2.  Pregnancy malaria: cryptic disease, apparent solution.

Authors:  Patrick Emmet Duffy; Michal Fried
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

Review 3.  The safety of antimalarial drugs in pregnancy.

Authors:  P A Phillips-Howard; D Wood
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

Review 4.  Protective efficacy of interventions for preventing malaria mortality in children in Plasmodium falciparum endemic areas.

Authors:  Thomas P Eisele; David Larsen; Richard W Steketee
Journal:  Int J Epidemiol       Date:  2010-04       Impact factor: 7.196

5.  Efficacy of malaria prevention during pregnancy in an area of low and unstable transmission: an individually-randomised placebo-controlled trial using intermittent preventive treatment and insecticide-treated nets in the Kabale Highlands, southwestern Uganda.

Authors:  Richard Ndyomugyenyi; Siân E Clarke; Coll L Hutchison; Kristian Schultz Hansen; Pascal Magnussen
Journal:  Trans R Soc Trop Med Hyg       Date:  2011-10-02       Impact factor: 2.184

6.  The Blantyre Integrated Malaria Initiative: a model for effective malaria control.

Authors:  Mary J Hamel; Christopher Mkandala; Nyson Chizani; Nyokase Kaimilla; Jim Kublin; Richard Steketee
Journal:  Malawi Med J       Date:  2002-04       Impact factor: 0.875

7.  Malaria prevention with IPTp during pregnancy reduces neonatal mortality.

Authors:  Clara Menéndez; Azucena Bardají; Betuel Sigauque; Sergi Sanz; John J Aponte; Samuel Mabunda; Pedro L Alonso
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

8.  Intermittent preventive treatment of malaria in pregnancy: a new delivery system and its effect on maternal health and pregnancy outcomes in Uganda.

Authors:  A K Mbonye; I C Bygbjerg; P Magnussen
Journal:  Bull World Health Organ       Date:  2008-02       Impact factor: 9.408

Review 9.  Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes.

Authors:  Bernard J Brabin; Teunis A Eggelte; Monica Parise; Francine Verhoeff
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 10.  Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.

Authors:  Philip J Peters; Michael C Thigpen; Monica E Parise; Robert D Newman
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.